Effect of verapamil on retrograde ventriculo-atrial conduction in children

Insights

Verapamil, a slow channel blocker, was studied in children undergoing cardiac catheterization. It was found to abolish retrograde atrioventricular (V-A) conduction, potentially explaining its antiarrhythmic effects on reentrant arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Pharmacology

Background:

  • Retrograde atrioventricular (V-A) conduction plays a role in reentrant arrhythmias.
  • Verapamil is a potent antiarrhythmic drug and a slow channel blocker.
  • Understanding verapamil's effect on V-A conduction is crucial for managing certain cardiac arrhythmias.

Purpose of the Study:

  • To investigate the effects of verapamil on retrograde V-A conduction in pediatric patients.
  • To determine if verapamil can abolish or prolong retrograde V-A conduction.
  • To correlate the observed effects with verapamil's antiarrhythmic properties.

Main Methods:

  • A study involving 12 children undergoing diagnostic cardiac catheterization.
  • Administration of a single intravenous dose of verapamil (0.15 mg/Kg).
  • Electrophysiological recordings including surface EKG, intra-atrial, and His bundle electrograms before and after verapamil administration.
  • Right ventricular pacing with extra stimulus technique was employed.

Main Results:

  • Verapamil prolonged the AH interval in 9 out of 12 children.
  • Retrograde V-A conduction was abolished in 5/12 children and prolonged in 1/12.
  • In all cases where retrograde V-A conduction was present, its duration exceeded antegrade conduction time.

Conclusions:

  • Verapamil effectively abolishes retrograde V-A conduction when present.
  • This abolition of retrograde V-A conduction may contribute to verapamil's antiarrhythmic efficacy in reentrant arrhythmias.
  • Verapamil demonstrates significant impact on cardiac electrophysiology, particularly concerning V-A pathways.

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...